Startups
AsedaSciences® helps scientists design safer compounds using integrated phenotypic screens and AI to predict toxicity risk earlier, helping to improve productivity for the chemical producing industries, reduce animal testing (3Rs), improve patient safety and safeguard the environment.
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 5, 2026 | AsedaSciences® and eMolecules Partner to Integrate Professional Compound Management Services into the 3RnD® Platform | Partnership strengthens the foundation for AI-ready data by integrating expert compound storage, preparation, QC and management into the 3RnD ecosystem. Through our partnership with eMolecules, we are establishing a robust foundation that s... |
| Jul 1, 2026 | AsedaSciences and Biobide Announce Strategic Agreement to Integrate Aquatic Toxicity Testing Services into 3RnD Platform | Partnership expands access to high-quality NAMs, streamlines ordering and data management, and enhances comparative toxicology insights for chemical developers This partnership represents a significant advancement in making high-quality NAM... |
| Mar 18, 2026 | AsedaSciences and EuroscreenFast Partner to add GPCR Screening of Chemicals into the 3RnD Toxicity Risk Ecosystem | Commercial sales and marketing agreement enhances 3RnD’s mechanistic toxicity screening panel, and expands the reach of EuroscreenFast’s GPCR portfolio Integration of GPCR screening into the 3RnD ecosystem is a pivotal step in delivering a ... |
| Apr 23, 2025 | AsedaSciences® Partners with Chemspace to Visualize 13 Billion Compounds on 3RnD® Cloud Platform | The world's largest synthesizable chemical library to be visualized in the 3RnD Compound Universe, enabling easy nearest neighbor identification and ordering By integrating the immense library offered by Chemspace into the 3RnD platform, we... |
| Mar 27, 2025 | AsedaSciences® and CellPort Software Announce Co-Marketing Agreement to Advance the Management of Cell-Based Assays | CellPort’s novel cell management software will be integrated into AsedaSciences’ 3RnD® platform, enhancing data traceability for cell-based New Approach Methods Efficient management of the traceability and reproducibility of cell-based assa... |
| Mar 17, 2025 | AsedaSciences® and Chayon Laboratories Announce Reseller Agreement to Expand Drug Discovery Solutions in South Korea | Agreement provides scientists with access to advanced predictive toxicology and safety assessment capabilities earlier in Drug Discovery We are excited to work with Chayon to bring our industry-leading solutions to the Korean market” — Brad... |
| Mar 10, 2025 | AsedaSciences and Excelra Announce a Co-Marketing Agreement to Deliver a Unified Data Platform for Small Molecules | Strategic agreement combines industry-leading data sets into a single, easy-to-use platform to support AI-driven insights earlier in Drug Discovery Integration of the GOSTAR and 3RnD platforms enables us to provide unique insights into the ... |
| Apr 17, 2024 | SciCrunch® and AsedaSciences® Partner to Empower Scientists and Institutions with Enhanced Research Solutions | Screenshot of new joint webpage SciScore logo Logo AsedaSciences The partnership between SciCrunch and AsedaSciences brings together two industry leaders committed to driving innovation and excellence in scientific inquiry. By leveraging th... |
Reviews 0
FAQ about AsedaSciences Home
What has the press written about AsedaSciences Home?
Parsers VC has collected 9 articles mentioning AsedaSciences Home, among them “AsedaSciences® and eMolecules Partner to Integrate Professional Compound Management Services into the 3RnD® Platform” (Aug 5, 2026) and “AsedaSciences and Biobide Announce Strategic Agreement to Integrate Aquatic Toxicity Testing Services into 3RnD Platform” (Jul 1, 2026).
Is AsedaSciences Home still active?
Yes, AsedaSciences Home is active; its latest activity on Parsers VC dates from Sep 29, 2026.